Cheryl Jones

Maverex Limited

Cheryl Jones is listed at Maverex Limited. Cheryl spoke at ISPOR Europe 2026 in November 2026 (speaker, “Converting Vaccine Evidence to Policy”). Speaks mainly at Government Administration events.

Compiled from published conference agendas; not yet confirmed by Cheryl. Is this you? Claim this profile.

• Sector: Government Administration

Sessions at 1 conference

ISPOR Europe 2026 8 November 2026 – 11 November 2026

• Converting Vaccine Evidence to Policy Speaker · 9 November 2026

Spoke alongside

People who have shared a session with Cheryl at events on B2DB.

• Isidoros Kougioumtzoglou University of West Attica 1 shared session
• Klas Bergenheim Director Health Economics & Payer Evidence V&I · AstraZeneca 1 shared session
• Patricia Pujol Medical Affairs Manager · GSK 1 shared session
• Tiberius Certejan Senior Director, Market Access and Government Affairs, Region Europe · Merz Therapeutics GmbH 1 shared session